Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
Read the official source — NCT02431845Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive
Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression
Read the official source — NCT06853587Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression
Pharmacogenetics of Antidepressant-Induced Disinhibition
Read the official source — NCT03953014Pharmacogenetics of Antidepressant-Induced Disinhibition in Children Study
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Read the official source — NCT06763081Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation in Children and Youth (PGx-SImBA)
Pharmacogenomics of Stimulant Treatment Response
Read the official source — NCT06221358Pharmacogenomics of Stimulant Treatment Response in Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Read the official source — NCT06929533Pharmacogenomics-Supported Psychotropic Prescribing Trial (PGx-SUPPORT): A Pilot Implementation Study in Manitoba
Pharmacokinetic Modeling of Methadone
Read the official source — NCT05490732Pharmacokinetic Population Modeling of Methadone in Patients Managed for Opioid Opioid Addiction
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Read the official source — NCT04278404Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
Read the official source — NCT07185815A Prospective, Dose Escalating, Open Label, Multi-center, Phase I/IIa Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine.
Pharmacologic Augmentation of TMS for Depression With D-serine
Read the official source — NCT06876129Pharmacologic Augmentation of TMS for Depression With D-serine
Pharmacologic Treatment Augmentation in Chronic Depression
Read the official source — NCT06410599Pharmacologic Treatment Augmentation in Chronic Depression "Randomized, Controlled, Double Blinded, Phase II Study"
Pharmacologic treatment augmentation in chronic depression randomized, controlled, double blinded, phase II study
Read the official source — 2019-001692-37Pharmacologic treatment augmentation in chronic depression randomized, controlled, double blinded, phase II study
Original registry wording; source language not specified.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including BerlinWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.